TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference

TransMedics (Nasdaq: TMDX) announced management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York.

Rhea-AI Summary

TransMedics (Nasdaq: TMDX) announced management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York.

The event is scheduled for Tuesday, December 2, 2025 at 9:30 a.m. ET at the Lotte New York Palace. A live and archived webcast will be available on the company's Investors website and the standard investor presentation is posted at the same link.

Argus Nov 19 session

+14.01% close to close 1.7x rel. volume Open Argus

Details

News Market Reaction – TMDX

On Nov 19, the first trading day after this news, TMDX closed 14.01% above the previous close. That session’s volume was 1.7x the stock’s average daily volume.

Data tracked by StockTitan Argus for the Nov 19 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., Nov. 18, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 37^th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 2, 2025, at 9:30 a.m. Eastern Time.

Event: Piper Sandler 37^th Annual Healthcare Conference
Date: Tuesday, December 2, 2025
Time: 9:30 a.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com.  The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302619165.html

SOURCE TransMedics Group, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will TransMedics (TMDX) present at the Piper Sandler 37th Annual Healthcare Conference?

TransMedics management will present on Tuesday, December 2, 2025 at 9:30 a.m. ET.

Where is the TransMedics (TMDX) fireside chat being held on December 2, 2025?

The fireside chat is at the Lotte New York Palace during the Piper Sandler conference.

How can investors watch the TransMedics (TMDX) fireside chat webcast?

A live and archived webcast will be available on TransMedics' Investors website at https://investors.transmedics.com.

Will TransMedics (TMDX) share its investor presentation at the Piper Sandler event?

Yes. The company's standard investor presentation is available via the same Investors website link.

Who from TransMedics (TMDX) will participate in the fireside chat?

Members of TransMedics' management team are scheduled to participate in the fireside chat.